MichelleAIavicoliMD

PubMed

• Humoral immunity in diabetic pregnancy: interrelationships with maternal/neonatal complications and maternal metabolic control.
  Fallucca F, Di Mario U, Gargiulo P, Iavicoli M, Galfo C, Contreas G, Pachi' A, Andreani D> ;Diabete Metab. 1985-12-01
• Lymphocyte subsets and immune complexes in long-standing diabetic patients: relation with the presence of microangiopathy.
  Andreani D, Di Mario U, Zuccarini O, Franco M, Sensi M, Iavicoli M, Pozzilli P> ;Immunol. Lett.. 1984-01-01
• [Insulin antibodies and immune complexes in long-term diabetics switched to monocomponent human insulin].
  Iavicoli M, Di Mario U, Coronel GA, Musacchio N, Arduini P> ;Minerva Endocrinol.. 1984-01-01
• Semisynthetic human insulin: biologic and immunologic activity in newly treated diabetic subjects during a six-month follow-up.
  Iavicoli M, Di Mario U, Coronel GA, Dawud AM, Arduini P, Leonardi M> ;Diabetes Care. 1984-01-01
• The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy.
  Di Mario U, Ventriglia L, Iavicoli M, Guy K, Andreani D> ;Clin. Exp. Immunol.. 1983-06-01
• Circulating immune complexes in diabetics: the influence of sex, age, duration of disease and type of treatment.
  Di Mario U, Irvine WJ, Guy K, Borsey DQ, Iavicoli M, Ventriglia L> ;J Clin Lab Immunol. 1983-05-01
• Monoclonal antibodies defined abnormalities of T-lymphocytes in type I (insulin-dependent) diabetes.
  Pozzilli P, Zuccarini O, Iavicoli M, Andreani D, Sensi M, Spencer KM, Bottazzo GF, Beverley PC, Kyner JL, Cudworth AG> ;Diabetes. 1983-01-01
• Aspects of humoral immunity in a prospective study of Type I (insulin-dependent) diabetic subjects treated with insulins of different purity.
  Iavicoli M, Ventriglia L, Di Mario U, Galfo C, Andreani D> ;Diabetologia. 1983-01-01
• Circulating immune complexes in diabetics with severe microangiopathy: evaluation by two different methods.
  Andreani D, Di Mario U, Galfo C, Ventriglia L, Iavicoli M> ;Acta Endocrinol.. 1982-02-01
• Impaired phagocytic function and increased immune complexes in diabetics with severe microangiopathy.
  Iavicoli M, Di Mario U, Pozzilli P, Canalese J, Ventriglia L, Galfo C, Andreani D> ;Diabetes. 1982-01-01
• New evidence of circulating immune complexes in Crohn's disease using two sensitive methods.
  Pallone F, Montano S, Ricci R, Iavicoli M, Di Mario U> ;J Clin Lab Immunol. 1981-01-01
• Circulating immune complexes in diabetes.
  Di Mario U, Iavicoli M, Andreani D> ;Diabetologia. 1980-08-01
• Increased lymphocyte transformation by insulin induced hypoglycaemia in normal subjects.
  Iavicoli M, Pozzilli P, Di Mario U> ;J Clin Lab Immunol. 1979-02-01
• Immune complexes and diabetic microangiopathy.
  Irvine WJ, Di Mario U, Guy K, Iavicoli M, Pozzilli P, Lumbroso B, Andreani D> ;J Clin Lab Immunol. 1978-11-01
• Glucagon and growth hormone secretion in insulin-treated diabetics: effects of added sulfonylureas.
  Fallucca F, Iavicoli M, Menzinger G, Mirabella C, Andreani D> ;Metab. Clin. Exp.. 1978-01-01
• Hypoglycaemic syndromes and antibodies to pancreatic islet cells.
  Di Mario U, Tamburrano G, Iavicoli M, Irvine WJ> ;Clin. Exp. Immunol.. 1977-09-01
• Comparative trials with monocomponent (MC) and monospecies (MS) pork insulins in the treatment of diabetes mellitus. Influence on antibody levels, on insulin requireme...
  Andreani D, Iavicoli M, Tamburrano G, Menzinger G, Maltarello C> ;Horm. Metab. Res.. 1974-11-01
• Insulin, glucagon and growth hormone in primary adult myxoedema.
  Andreani D, Fallucca F, Tamburrano G, Iavicoli M, Menzinger G> ;Diabetologia. 1974-02-01
• [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
  Andreani D, Iavicoli M, Colletti A, Menzinger G> ;Folia Endocrinol. 1972-12-01
• Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients.
  Rivellese, A. A., Patti, L., Romano, G., Innelli, F., Di Marino, L., Annuzzi, G., Iavicoli, M., Coronel, G. A., Riccardi, G.> ;J Clin Endocrinol Metab. 2000 Nov
• Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?
  Romano, G., Patti, L., Innelli, F., Di Marino, L., Annuzzi, G., Iavicoli, M., Coronel, G. A., Riccardi, G., Rivellese, A. A.> ;Diabetes. 1997 Oct
• Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment.
  Valcavi, R., Gaddi, O., Zini, M., Iavicoli, M., Mellino, U., Portioli, I.> ;J Clin Endocrinol Metab. 1995 Feb
• Reduction in insulin antibodies 42 months after transfer from porcine to human monocomponent insulins.
  Virgili, F., Frigato, F., Magnanini, P. G., Coronel, G. A., Iavicoli, M.> ;Diabetes Res. 1988 Sep
• When to start an NIDDM patient on insulin. Which insulin programme could be recommended?
  Maldonato, A., Iavicoli, M., Fallucca, F.> ;Diabetes Res Clin Pract. 1988
• Blood glucose control and insulin secretion improved with combined therapy in type 2 diabetic patients with secondary failure to oral hypoglycaemic agents.
  Iavicoli, M., Cucinotta, D., De Mattia, G., Lunetta, M., Morsiani, M., Pontiroli, A. E., Pozza, G.> ;Diabet Med. 1988 Dec
• Join now to see all